Commercial Development: In August 2025, Jocasta Neuroscience raised $35 million in Series A funding to advance JN-0413, a proprietary -klotho formulation, through Phase 1 trials with IND submission planned for Q4 2026
The peptide supports the healing of various tissues such as: skin tendon ligament muscle bone This broad spectrum of healing capabilities means that BPC 157 can be used in a variety of medical scenarios, from treating skin wounds to aiding in bone healing
What Affects the Speed of Weight Loss
Ohkusa T, Koido S, Nishikawa Y, et al
Testosterone replacement for aging men: indications, benefits, and safe clinical management [39:45]
He only gives certain dosages for a limited amount of time, he said